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ABSTRACT
Amongst the different delivery methods to the eye, an in-situ forming hydrogel is 
considered as one of the most effective delivery methods. An in-situ forming hvdrogel 
is a formulation that can undergo gelation in response to the variations in its external 
environment. The pH triggered in-situ ophthalmic gel systems have been widely 
investigated in regard to their spontaneity of gelation, gel system characterization, in- 
vitro drug release and ophthalmic compatibility. However the involved energetics and 
thermodynamics related to the phenomenon of sol-gel transition have been investigated 
sporadically. Hence the present study aimed to examine and elucidate the involved 
energetics and thermodynamics during the sol-gel transitions of carbopol in the 
presence of viscosity-enhancing agents such as Hydroxypropyl Methylcellulose 
(HPMC) and surfactant such as Benzalkonium chloride (BKCL). Using viscometric 
and conductometric titration, various concentrations of carbopol and carbopol-based 
solution systems in the presence of HPMC and BKCL were analyzed to determine the 
thermophysical parameters such as molar conductivity (k), activation energy (E*), 
enthalpy (AH), entropy (AS), Gibb’s free energy (AH) and heat capacity (ACP) of the 
systems. These parameters were discussed in terms of the phenomena of sol-gel 
transitions, emphasizing the effect of polymer concentration and the presence of co­
excipients such as HPMC and BKCL. Based on the thermophysical experimentations, 
the suitable concentrations of carbopol, HPMC and BKCL was selected for use in the 
optimized formulation. The optimized formulation was achieved by incorporating 
buffering agents such as citric acid and sodium dihidrogen phosphate, and various 
concentrations of chitosan for added anti-microbial and mucoadhesive activity. The 
formulation optimization was carried out on the basis of parameters such as viscosity, 
surface tension and spontaneity of gelation. The pH adjustment was done by varying 
the concentration of sodium hydroxide and accordingly the suitable formulations were 
selected. The drug nepafenac was investigated as a model drug .The optimized 
formulations were further characterized for the in-vitro drug release study. The data 
related to drug release studies were treated using the release kinetic models and the 
optimized in-situ gel resulted in a controlled release (with a release index of 0.538 for 
Fu) of the candidate drug nepafenac.
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CHAPTER ONE 
INTRODUCTION
1.1 BACKGROUND OF STUDY
Ophthalmic drug delivery is one of the most interesting and challenging efforts 
for the pharmaceutical formulators. The eye possesses a special anatomic structure and 
very efficient protective mechanisms, as a result of which many challenges are 
presented during the formulation development stage. The tear flow and the blinking 
reflex remove foreign materials from the eye and maintain a good environment of the 
eye. However these protective properties also lead to an effective drainage of the drugs, 
when instilled into the eye. This causes low ocular bioavailability that is commonly less 
than 10% [1, 2, 3], owing to short ocular residence time resulting in a reduced 
therapeutic effect of the drug. The nasolacrimal drainage is another route for the drug 
to enter the circulatory system during topical administration. If the drug is potent, then 
the systemic exposure through nasolacrimal drainage after topical administration can 
cause systemic toxicity [4],
By increasing the viscosity of the vehicle, the drainage rate can be decreased 
and the residence time of the ophthalmic eye drop can be increased. This method only 
moderately affects the contact time of the drug. Though ointment provides long 
residence time, it is associated with a low patient compliance and only can be used at 
bed time. The ocusert i.e. ocular insert can also provide a long residence time that can 
deliver the drug at a desired rate for a prolonged period of time. In case of ocuserts, the 
patient compliance is low.
Gel systems are better retained in the eye than conventional eye drops and are 
better tolerated by patients than inserts and ointments. The use of preformed hydrogels 
has drawbacks that can limit their interest. They do not allow accurate and reproducible 
administration of drugs, and after administration, they often produce blurred vision, 
crusting of eye lids and lacrimation [5],
A new approach is to combine the advantage of both solutions and gels such as 
accuracy and facility of administration of the former and prolonged residence time of 
the latter. The in-situ gels can be instilled as eye drops and undergo an immediate 
transition in to gel as it contacts the eye. These in-situ gels are liquid upon instillation
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